Updated just now · Live
Stock analysis, price data, and AI-powered insights for NewAmsterdam Pharma Company NV (NAMS).
NewAmsterdam Pharma Company NV operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for NAMS.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). NAMS Stock Intelligence Report. [stoxpulse.com/stocks/nams]
Disclaimer: The information on this page about NewAmsterdam Pharma Company NV (NAMS) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for NewAmsterdam Pharma Company NV.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
NewAmsterdam Pharma: Cholesterol-Lowering Player I...
5d ago
StoxPulse AI results for NAMS: Pulse Score 45/100. Primary sentiment trends from 1 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$3.89B
P/E Ratio
—
EPS
$-0.61
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—